Merger suits prompt extra disclosures by Rayonier and PotlatchDeltic (PCH)
Rhea-AI Filing Summary
Rayonier Inc. and PotlatchDeltic Corporation report shareholder litigation and related demands challenging disclosures in their previously filed joint proxy statement and prospectus for their proposed merger. The complaints and demand letters allege disclosure deficiencies and seek additional information about the transaction. Both companies state they believe these claims are without merit but are providing supplemental disclosures to moot the disclosure claims, avoid nuisance, cost and distraction, and reduce the risk of delay to completing the merger, without admitting wrongdoing or materiality.
The added details expand on the financial advisors’ valuation work, including discounted cash flow assumptions, discount rates, perpetuity growth rates, EBITDA multiples, analyst price target ranges and treatment of net debt and fully diluted share counts for each company. The filing also reiterates extensive forward‑looking risk factors related to the merger’s completion, expected synergies, industry conditions, and regulatory and shareholder approvals, and reminds investors to review the effective Form S‑4 and joint proxy statement/prospectus before voting.
Positive
- None.
Negative
- None.
FAQ
What merger are Rayonier Inc. and PotlatchDeltic Corporation pursuing?
Rayonier Inc. has agreed to acquire PotlatchDeltic Corporation through a merger in which PotlatchDeltic will merge with and into a wholly owned Rayonier subsidiary, with that subsidiary surviving as a direct, wholly owned subsidiary of Rayonier. The transaction is governed by an Agreement and Plan of Merger signed on October 13, 2025.
What litigation and demands have been filed regarding the Rayonier–PotlatchDeltic merger?
As of this report, three complaints have been filed challenging the merger: Siegel v. Alonzo et al. in Washington state court and Walsh v. PotlatchDeltic Corporation et al. and Miller v. PotlatchDeltic Corporation et al. in New York state court. Rayonier and PotlatchDeltic have also received demand letters from purported shareholders and stockholders alleging disclosure deficiencies in the joint proxy statement/prospectus and seeking additional disclosures.
How are Rayonier and PotlatchDeltic responding to the merger-related lawsuits and demand letters?
The companies state they believe the allegations are without merit and that their existing joint proxy statement/prospectus complies with applicable law and exchange rules. Nonetheless, to moot the disclosure claims, avoid nuisance, cost and distraction, and preclude efforts to delay completion of the merger, they are voluntarily providing supplemental disclosures without admitting any culpability, liability, wrongdoing, or materiality of the additional information.
What type of supplemental financial information is being disclosed for the merger?
The supplemental information expands descriptions of the valuation work performed by Morgan Stanley and BofA Securities. It provides more detail on discounted cash flow analyses, including perpetuity growth rates, discount rates and implied per-share value ranges, as well as EBITDA multiples used in comparable company analyses, analyst price target ranges and the net debt and fully diluted share counts applied in deriving implied equity values for Rayonier and PotlatchDeltic.
When will Rayonier and PotlatchDeltic security holders vote on the proposed merger?
Each company will hold a special meeting of its shareholders or stockholders on January 27, 2026 to consider matters related to the merger, as described in the joint proxy statement/prospectus that forms part of Rayonier’s effective Form S‑4 registration statement.
Where can investors find the joint proxy statement/prospectus and related merger documents?
The joint proxy statement/prospectus is included in Rayonier Inc.’s registration statement on Form S‑4 filed with the SEC. Investors can obtain the documents filed by PotlatchDeltic Corporation and Rayonier Inc. free of charge from their respective websites or from the SEC’s website at www.sec.gov, as referenced in the communication.
Does this communication constitute an offer to sell securities of Rayonier or PotlatchDeltic?
No. The communication explicitly states it does not constitute an offer to sell or the solicitation of an offer to buy any securities, and that no sale will occur in any jurisdiction where it would be unlawful before proper registration or qualification. Any securities offering will be made only by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.